Alembic Pharmaceuticals jumps on getting USFDA’s tentative approval for Dronedarone Tablets USP
Alembic Pharmaceuticals is currently trading at Rs. 816.90, up by 10.15 points or 1.26% from its previous closing of Rs. 806.75 on the BSE. The scrip opened at Rs. 809.00 and has touched a high and low of Rs. 820.00 and Rs. 807.85 respectively. So far 8673 shares were traded on the counter. The BSE … Read more



